|
|
 |
|
Drug Testing Home |
IOC Anti-Doping Code |
Links |
Anabolic Steroid Alternatives |
|
|
I. PROHIBITED CLASSES OF SUBSTANCES
I.A. Stimulants
Prohibited substances in this class include the following
examples with both their L and D-isomers.
1. Stimulants
|
Amfepramone |
Fencamfamin |
Norphenfluramine |
|
Amfetamine |
Fenetylline |
Parahydroxyamfetamine |
|
Amiphenazole |
Fenfluramine |
Pemoline |
|
Bromantan |
Fenproporex |
Pentetrazol |
|
Caffeine* |
Heptaminol |
Phendimetrazine |
|
Carphedon |
Mefenorex |
Phenmetrazine |
|
Cathine** |
Mephentermine Phentermine |
|
|
Clobenzorex |
Mesocarb |
Phenylpropanolamine** |
|
Cocaine |
Metamfetamine Pholedrine |
|
|
Cropropamide |
Methoxyphenamine Pipradrol |
|
|
Crotetamide |
Methylendioxyamfetamine Prolintane Methylendioxymetamfetamine |
|
|
Ephedrine** |
Propylhexedrine |
|
|
Etamivan |
Methylephedrine** Pseudoephedrine** |
|
|
Etilamfetamine |
Methylphenidate |
Selegiline |
|
Etilefrine |
Nikethamid |
Strychnine |
and related substances
* For caffeine the definition of a positive is a concentration
in urine greater than 12 μg/ml.
** For cathine, the definition of a positive is a
concentration in urine greater than 5 μg/ml.
For ephedrine and methylephedrine, the definition of a positive is a
concentration in urine greater than 10 μg/.
For phenylpropanolamine and pseudoephedrine, the definition of a positive is a
concentration in urine greater than 25
μg/ml.
Note All imidazole preparations
are acceptable for topical use. Vasoconstrictors may be administered with local
anaesthetic agents. Topical preparations (e.g. nasal, ophthalmological, rectal)
of adrenaline are permitted. The use of bupropion, synephrine and phenylephrine
is permitted.
2. Beta-2-Agonists
|
Bambuterol |
Reproterol |
Salmeterol* |
|
Formoterol* |
Salbutamol* |
Terbutalin* |
and related substances
* Formoterol, Salbutamol, Salmeterol and Terbutalin permitted
by inhaler only to prevent and/or treat asthma and exercise-induced asthma.
Written notification by a respiratory or team physician that the athlete has
asthma and/or exercise-induced asthma is necessary to the relevant medical
authority prior to competition (written notification to the specially assigned
Medical Doctor of the Anti-Doping Commission). At the Olympics Games, athletes
who request permission to inhale a permitted beta-2 agonist, will be assessed
by an independent medical panel.
I.B. Narcotics
|
Buprenorphine |
Hydrocodone |
Pentazocine |
|
Dextromoramide |
Methadone |
Pethidine |
|
Diamorphine (Heroin) |
Morphine* |
|
and related substances
*For morphine the definition of a positive is a concentration in
urine greater than 1 g/ml
Note: codeine, dextromethorphan,
dextropropoxyphene, dihydrocodeine, diphenoxylate, ethylmorphine, pholcodine,
propoxyphene and tramadol are permitted.
I.C. Anabolic Agents
1. Anabolic androgenic steroids
|
Androstendiol |
Fluoxymesterone 19- |
Norandrostendiol |
|
Androstendione |
Formebolone 19- |
Norandrostendione |
|
Bolasterone |
Gestrinone |
Norboletone |
|
Boldenone |
Mesterolone Norethandrolone |
|
|
Clostebol |
Metandienone Oxandrolone |
|
|
Danazol Dehydrochlormethyltestosterone |
Metenolone Oxymesterone |
|
|
|
Methandriol |
Oxymetholone |
|
Dehydroepiandrosterone (DHEA) |
Methyltestosterone |
Stanozolol |
|
Dihydrotestosterone |
Mibolerone |
Testosterone* |
|
Drostanolone |
Nandrolone |
Trenbolone |
and related substances
Note: Evidence
obtained from metabolic profiles and/or isotopic ratio measurements may be used
to draw definitive conclusions.
* The presence of a testosterone (T) to epitestosterone (E)
ratio greater than six (6 )to one (1) in the urine of a competitor constitutes
an offence unless there is evidence that this ratio is due to a physiological
or pathological condition, e.g. low epitestosterone excretion, androgen
producing tumour, enzyme deficiencies.
In the case of T/E greater than 6, it is mandatory that the
relevant medical authority conducts an investigation before the sample is
declared positive. A full report will be written and will include a review of
previous tests, subsequent tests and any results of endocrine investigations.
In the event that previous tests are not available, the athlete should be
tested unannounced at least once per month for three months. The results of
these investigations should be included in the report. Failure to cooperate in
the investigations will result in declaring the sample positive.
2. Other anabolic agents
|
Bambuterol |
Formoterol* |
Salmeterol* |
|
Clenbuterol |
Reproterol |
Terbutaline* |
|
Fenoterol |
Salbutamol*° |
|
and related substances
* Ref. I.A.2. Beta-2-Agonists
° For salbutamol, a concentration in urine greater than 1000
nanograms per millilitre of non-sulphated salbutamol constitutes a doping
violation.
I.D. Diuretics
|
Acetazolamide |
Chlortalidone |
Mannitol* |
|
Amiloride |
Etacrynic acid Mersalyl |
|
|
Bendroflumethiazide |
Furosemide |
Spironolactone |
|
Bumetanide |
Hydrochlorthiazide Torasemide |
|
|
Canrenone |
Indapamide |
Triamterene |
and related substances
* Prohibited by intravenous injection.
I.E. Peptide hormones, mimetics and analogues
1. Chorionic Gonadotrophin (hCG)*
2. Pituitary and synthetic gonadotrophins (LH)*
3. Corticotropins (ACTH, tetracosactid)
4. Growth hormone (hGH)
5. Insulin-like Growth Factor(IGF-1)
6. Erythropoietin (EPO)
7. Insulin**
* prohibited in males only
** permitted only to treat athletes with certified
insulin-dependent diabetes. The term ‘insulin-dependent’ is used here to
describe people with diabetes in whom insulin treatment is required, in the
judgement of a suitably qualified physician. It will always be the case in
Type 1 and sometimes in Type 2 diabetes mellitus.
Written certification of insulin-dependent diabetes must be
obtained from an endocrinologist or team physician.
Note: Prohibited are
all the respective releasing factors and their analogues. The presence of an
abnormal concentration of an endogenous hormone or its diagnostic marker(s) in
the urine of a competitor constitutes an offence unless it has been proven to be
due to a physiological or pathological condition.
I.F. Agents with anti-oestrogenic activity
|
Clomiphene* |
Cyclofenil* |
Tamoxifen* |
* prohibited in males only
I.G. Masking Agents
Masking agents are prohibited. They are products that have
the potential to impair the excretion of prohibited substances or to conceal
their presence in urine or other samples used in doping control.
Epitestosterone*
Probenecid
Plasma expanders
(e.g. hydroxyethyl starch (HES)
* The presence of a urinary concentration of
epitestosterone greater than 200 ng/mL constitutes an anti-doping violation
unless there is evidence that it is due to a physiological condition. Isotopic
ratio mass spectrometry (IRMS) may be used to draw definitive conclusions. If
the results of the IRMS are inconclusive, the relevant medical authority shall
conduct an investigation before the sample is declared positive.
|
|
Training and nutrition: supplements, fitness, diet and fat loss coaching service. We are your online professional health and fitness coach for the 21st Century, providing advice and instruction.
|
|
|